iPSCs : Recent Clinical Insights & Progress
SPEAKERS
Prof. Dan S. Kaufman
Professor, Department of Medicine
Co-director of Sanford Stem Cell Institute
San Diego, USA
Endowed Chair Director,
Cell Therapy Program
Sanford Advanced Therapy Center, USA
Prof. Ali Turhan
Professor of Hematology School of Medicine
Paris Saclay University, France
Director of Clinical iPSC Program at CiTHERA/ INSERM U1210, France
Co-founder iPSirius
Prof. Frank Griscelli
Professor of Biotherapy
Paris Cité University, and Institut Gustave Roussy, France
Director of INSERM U1310, France
Co-Founder of iPSirius
Dr. Naosuke Nakamura
Assistant Professor
CiRa Foundation, Japan
Prof. Haruhisa Inoue
Assistance Director
Center for iPS Cell Research and Application (CiRA)
Kyoto University, Japan
Representative Director of the Japan Disease Stem Cell Society
Prof. Keiichi Fukuda
Chief Executive Officer
Representative Director of the Board,
Heartseed Inc., Tokyo, Japan
Prof. Ronald Li
Founder & CEO of
NovoHeart, Hong Kong
Medera, Boston USA
Prof Jung-Hyun Kim
Professor at Ajou University College of Pharmacy, Korea
Former Director of the Korea National Stem Cell Bank at the Korea National Institute of Health(KNIH)
Prof. Ji Hyeon Ju
Professor of Rheumatology, The Catholic University of Korea
CEO of YiPSCELL
Director of the Clinical Academic Committee of the Korea Society of Stem Cell Research (KSSCR)
Prof. Jihwan Song
Professor, Department of Biomedical Science,
CHA University,
Founder & CEO of iPS Bio Inc., South Korea
Dr. Anselme L. Perrier
Research Director at INSERM
Group leader at the CEA/CNRS U9199 Laboratory of Neurodegenerative Diseases, MIRCEN Infrastructure, France
Prof. Christelle Monville
Professor,
University of Evry
Team Leader at
I-Stem INSERM U861, France
Dr. Peter Andersen
Chief Research & Development Officer at
Treefrog Therapeutics, France
Dr Alex Ng
Co-founder & Chief Innovation Officer of
GC Therapeutics, USA
Dr. Boris Greber
Managing Director and Head of R&D
Catalent, Germany
Dr Alex Zhang
Chief Scientific Officer of
Zephyrm Biotechnologies, China
Prof. Anna Veiga
Director of the Barcelona Stem Cell Bank
Group leader at Pluripotent Stem Cell Therapy research group at the Regenerative Medicine Program (REGENBELL) at Institut d’ Investigació Biomèdica de Bellvitge (IDIBELL), Spain
Prof. Annelise Bennaceur Griscelli
Professor Hematology
School of Medicine
Paris Saclay University,
Director of CiTHERA, the Center for iPS Cell Therapies
Coordinator of The National iPSC Infrastructure INGESTEM,
Co-Founder of iPSirius
Prof. Anna Falk
Professor Stem Cell Center, Lund University, Sweden
Director of the Lund University ATMP Centre
Director of the PreGMP facility
CSO at CCRM Nordic, Sweden
Prof. Andras Nagy
Professor at
Institute of Medical Science
University of Toronto, Canada
Professor at
Australian Regenerative Medicine Institute,
Monash University, Australia
Prof. Hongkui Deng
Boya Chair Professor of Cell Biology,
Peking University Health Science Center
School of Basic Medical Sciences
Director of Peking University Stem Cell Research Center, China
Dr. Marcelo Rivolta
Professor of Sensory Stem Cell Biology
University of Sheffield, UK
Founder & CSO
RINRI Therapeutics, UK
Dr. Glyn Stacey
Professor at the Universities of Bedfordshire and Suffolk,UK
Institute of Stem Cell and Regeneration, CAS, Beijing, China
SCIENTIFIC ADVISORY BOARD
The Agenda has been setup by the Scientific Advisory Board composed of the following Experts :
Prof. Annelise Bennaceur Griscelli
Professor Hematology
School of Medicine
Paris Saclay University,
Director of CiTHERA, the Center for iPS Cell Therapies
Coordinator of The National iPSC Infrastructure INGESTEM,
Co-Founder of iPSirius
Prof. Ali Turhan
Professor of Hematology
School of Medicine
Paris Saclay University, France
Director of Clinical iPSC Program at CiTHERA/ INSERM U1210, France
Co-founder iPSirius
Prof. Anna Veiga
Director of the Barcelona Stem Cell Bank
Group leader at Pluripotent Stem Cell Therapy research group at the Regenerative Medicine Program (REGENBELL) at Institut d’ Investigació Biomèdica de Bellvitge (IDIBELL), Spain
Dr. Glyn Stacey
Professor at the Universities of Bedfordshire and Suffolk,UK
Institute of Stem Cell and Regeneration, CAS, Beijing, China
Dr. Anselme L. Perrier
Research Director at INSERM
Group leader at the CEA/CNRS U9199 Laboratory of Neurodegenerative Diseases,MIRCEN Infrastructure, France
Dr. Pierre Savatier
Research Director at INSERM
Stem-cell & Brain Research Institute (SBRI)
National Pluripotent Stem Cell Infrastructure INGESTEM, France